These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26037685)

  • 1. Practical pharmacotherapy for acute schizophrenia patients.
    Hatta K
    Psychiatry Clin Neurosci; 2015 Nov; 69(11):674-85. PubMed ID: 26037685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy.
    Hatta K; Sugiyama N; Ito H
    Ther Adv Psychopharmacol; 2018 Jun; 8(6):173-183. PubMed ID: 29854396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia.
    Hatta K; Ito H
    Clin Psychopharmacol Neurosci; 2014 Apr; 12(1):1-7. PubMed ID: 24851115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
    Constantine RJ; Andel R; McPherson M; Tandon R
    Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
    Dold M; Li C; Gillies D; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
    Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
    Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective.
    Dold M; Leucht S
    Evid Based Ment Health; 2014 May; 17(2):33-7. PubMed ID: 24713315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Borlido C; Remington G; Graff-Guerrero A; Arenovich T; Hazra M; Wong A; Daskalakis ZJ; Mamo DC
    J Clin Psychiatry; 2016 Jan; 77(1):e14-20. PubMed ID: 26845273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment strategies for schizophrenia.
    Lindenmayer JP; Khan A
    Expert Rev Neurother; 2004 Jul; 4(4):705-23. PubMed ID: 15853589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal Antipsychotic Dose and Dosing Interval in the Treatment of Schizophrenia].
    Takeuchi H
    Seishin Shinkeigaku Zasshi; 2015; 117(7):562-7. PubMed ID: 26552322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.
    Hatta K; Hasegawa H; Imai A; Sudo Y; Morikawa F; Katayama S; Watanabe H; Ishizuka T; Nakamura M; Misawa F; Fujita K; Ozaki S; Umeda K; Nakamura H; Sawa Y; Sugiyama N;
    Asian J Psychiatr; 2019 Feb; 40():82-87. PubMed ID: 30772732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.